Our C Blanke, SWOG Chair blog:
Biospecimen Quality: Protecting the Value of Our Biobank Currency
Getting full value from our biobank resources requires that submissions be of consistently high quality. We've posted new resources to help make that easier to achieve.
swog.org/news-events/ne…

Our #TranslationalMedicine link of the week, chosen by SWOG Cancer Research Network's Lee Ellis & Jimmy Rae, PhD:
Targeting KRAS in Cancer
doi.org/10.1038/s41591…

Do you have an inherited (germline) BRCA gene mutation and #pancreatic cancer that has spread (metastasized)? You may be eligible for the S2001 study. Learn more at swog.org/S2001. Or call 1-800-4-CANCER. #pancsm PanCAN

I see one of our new SWOG Cancer Research Network patient advocates, Lee Moultrie. Great piece, KFF Health News! And great work, Lee!

Our latest news - and upcoming SWOG Cancer Research Network funding opportunities. Don't miss these deadlines ✅ #SWOGonc

conta.cc/49NTUtC

. SWOG Cancer Research Network S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease ( #mmMRD ) to direct Therapy Duration (DRAMMATIC) - Dr. Amrita Krishnan Hoering, Phari Sexton, Robert Z. Orlowski #ASH20 Abst 1515 ow.ly/U9xg50FYWgt #NCT04071457 #mmsm

SWOG has given us the opportunity to do a national immunotherapy trial for rare tumors— huge unmet need.

Opened at >1,000 sites at its peak.

DART. The trial that keeps on giving.

Nivo and ipi in rare cancers.

Kudos to Drs Sandip Patel & Young Chae who made it happen.

Also links to the Spanish-language version of the S2108CD patient-friendly summary, yet another #plainlanguage resource only possible thanks to support from The Hope Foundation for Cancer Research! swog.org/resumen-del-en…

. SWOG Cancer Research Network S1803 Ph3 Len +/- Daratumumab/rhuph20 as Post-ASCT Maintenance in Myeloma Using Minimal Residual Disease ( #mmMRD ) to direct Therapy Duration (DRAMMATIC) - Dr. Amrita Krishnan Hoering, Phari Sexton, Robert Z. Orlowski #ASH20 Abst 1515 ow.ly/U9xg50FYWgt #NCT04071457 #mmsm

Onc discussion have to become fully patient-centered. Most are compassionate but biased towards longevity and many have this archaic notion SOC longevity care for all.

Let’s hope more have wisdom to finally elicit true pt priorities.
Gary Lyman 🇺🇸🇪🇺🇺🇦💛💙 SWOG Cancer Research Network Amanda Nizam, MD OncoAlert

Team Hope cyclists led by Dr. Parminder Singh raised $12,608 for The Hope Foundation at the 2024 Tour de Scottsdale! 💯🎉Parminder singh SWOG Cancer Research Network

Our C Blanke, SWOG Chair blog:
More Results: SWOG Trials That Keep on Giving
To keep @SWOG members informed of our research results, I'm highlighting important findings presented at two recent meetings, in #prostate cancer and rare #sarcomatoid carcinoma lung tumors
swog.org/news-events/ne…

Our #TranslationalMedicine link of the week, chosen by SWOG Cancer Research Network's Lee Ellis & Jimmy Rae, PhD:
Modulating Gut Microbiome in Cancer Immunotherapy: Harnessing Microbes to Enhance Treatment Efficacy
doi.org/10.1016/j.xcrm…

Nice highlight of SWOG Cancer Research Network co-chair Barbara Segarra in FDA Oncology newsletter. What an honor to serve beside her! content.govdelivery.com/accounts/USFDA…

And if you see high volume metastatic prostate cancer patients and have access, please support SWOG Cancer Research Network 1802! Brian F. Chapin

Next up on our program calendar - the virtual grant writing workshop! Applications due May 1 #SWOGonc

We invite participants across the #NCTN - open to members of NRG Oncology ECOG-ACRIN Cancer Research Group Children’s Oncology Group Alliance for Clinical Trials in Oncology too! Please encourage colleagues to apply! w/SWOG Cancer Research Network
thehopefoundation.org/funding-opport…

Meet the youngest SWOG Cancer Research Network members - daughters of Parminder singh Mayo Clinic Comprehensive Cancer Center - running the The Hope Foundation for Cancer Research booth at #TourDeScottsdale ! So impressive to see these amazing youngsters disseminating important insights around #cancerresearch - stop by the booth for a beautiful…

Amazing to see SWOG Cancer Research Network 1216 continue to bear fruit. Kudos to Neeraj Agarwal, MD, FASCO Huntsman Cancer Institute for fostering younger investigators’ careers via providing an opportunity to conduct secondary analyses. Here, #DrMamtaParikh UC Davis Comprehensive Cancer Cent leads an analysis of PSA at 3/7 mos post start of ADT.…

Just in 👉data from SWOG Cancer Research Network 1216 trial in mHSPC#prostatecancer👉 PSA level at 3 and 7 months after starting ADT Rx are strongly prognostic of OS: It’s time to design de- or escalation trials based on response biomarkers. OPEN access👉 tinyurl.com/3azhpt4r OncoAlert UroToday.com